Thomas Keuer
Directeur Général chez ARCA BIOPHARMA, INC.
Fortune : 142 148 $ au 30/04/2024
Postes actifs de Thomas Keuer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARCA BIOPHARMA, INC. | Directeur Général | 03/04/2024 | - |
| President | 03/04/2024 | - | |
| Directeur des opérations | 01/12/2014 | 03/04/2024 | |
| Corporate Officer/Principal | 01/10/2006 | 01/12/2014 |
Historique de carrière de Thomas Keuer
Anciens postes connus de Thomas Keuer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Directeur des opérations | - | 29/01/2009 |
| INSMED INCORPORATED | Directeur des opérations | 01/01/2004 | 01/11/2006 |
| BAXTER INTERNATIONAL INC. | Directeur Technique/Scientifique/R&D | 01/01/1998 | 01/01/2004 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/01/1998 | 01/01/2004 |
Somatogen, Inc.
 Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO. | Directeur des opérations | - | - |
Formation de Thomas Keuer
| The University of Texas at Austin | Undergraduate Degree |
| Rice University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Chief Operating Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| ARCA BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Health Technology |
Somatogen, Inc.
Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO. | Health Technology |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
- Bourse
- Insiders
- Thomas Keuer
- Expérience
